CHARLOTTESVILLE, VA, September 30, 2024 – AgroSpheres Inc. (AGS), a biotechnology leader in sustainable crop protection and crop health, today announced the final close of a $37 million Series B funding round led by...

by Ryan Cross Senior Science Correspondent, Endpoints A reversible male contraceptive could be a lot closer to reality than you think. Earlier this summer, doctors were tantalized by preliminary data...

reposted from Fierce Biotech Rivus Pharmaceuticals has plumped up the prospects of its fat-busting, muscle-sparing drug candidate, reporting a primary endpoint hit in a phase 2a trial of people with obesity-related heart...

AMPEL BioSolutions is a precision medicine company commercializing a development pipeline of CLIA-certified gene expression tests for blood or tissue samples that provide clinical decision support.

CHARLOTTESVILLE, Va., Dec. 14, 2022 /PRNewswire/ — BrightSpec, Inc., a life science tools company commercializing Molecular Rotational Resonance (MRR) spectroscopy, announced today the closing of an $18.4 million Series C financing round, led by...

AMPEL BioSolutions announces genomic analysis and findings that could improve treatment of COVID19 patients with approved drugs such as Embrel and Stelara.

Planned study features noted principal investigator, regulatory flexibility, and immediate availability of patients.

Join CvilleBioHub in San Francisco in mid-January at the 30th Annual J.P. Morgan Healthcare Conference and connect with high profile investors and meet other companies from the Commonwealth.

The CvilleBioHub has been awarded $548,000 from the GO Virginia initiative to lead the growth and expansion of the biotechnology innovation cluster in Central Virginia.

ZielBio, Inc., an early-stage biotechnology company that identifies novel high value disease targets and develops therapeutic interventions to improve patient outcomes, has closed a $25.1 million Series A financing round.